292 related articles for article (PubMed ID: 12083131)
1. Recombinant DNA: triumph or Trojan horse?
Holtzman E
Man Med; 1977; 2(2):83-103, W7. PubMed ID: 12083131
[No Abstract] [Full Text] [Related]
2. The perils of knitting new life.
Lappé M
Am Biol Teach; 1977 Apr; 39(4):200-206, 210. PubMed ID: 11650656
[No Abstract] [Full Text] [Related]
3. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark.
Baark E; Jamison A
Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912
[No Abstract] [Full Text] [Related]
4. Playing God with DNA.
Lubow A
New Times; 1977 Jan; 8(1):48-49+. PubMed ID: 11661390
[No Abstract] [Full Text] [Related]
5. The regulation of recombinant DNA research: the alternative of local control.
Rosenblatt DP
Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694
[No Abstract] [Full Text] [Related]
6. Science that frightens scientists: the great debate over DNA.
Bennett W; Gurin J
Atl Mon; 1977 Feb; 237(2):43-50+. PubMed ID: 11661393
[No Abstract] [Full Text] [Related]
7. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after.
Barkstrom JE
Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740
[No Abstract] [Full Text] [Related]
8. Risks and benefits, rights and responsibilities: a history of the recombinant DNA research controversy.
Swazey JP; Sorenson JR; Wong CB
South Calif Law Rev; 1978 Sep; 51(6):1019-78. PubMed ID: 11661650
[No Abstract] [Full Text] [Related]
9. Scientists and the control of science.
Singer M
New Sci; 1977 Jun; 74(1056):631-4. PubMed ID: 11663771
[No Abstract] [Full Text] [Related]
10. Recombinant DNA: a case study in regulation of scientific research.
Chalfant JC; Hartmann ME; Blakeboro A
Ecol Law Q; 1979; 8(1):55-129. PubMed ID: 11665069
[No Abstract] [Full Text] [Related]
11. State biotechnology oversight: the juncture of technology, law, and public policy.
Vito CC
Maine Law Rev; 1993; 45(2):329-83. PubMed ID: 11652701
[No Abstract] [Full Text] [Related]
12. Recombinant DNA and technology assessment.
Georgetown Law J; 1977; 11(4):785-878. PubMed ID: 11664859
[No Abstract] [Full Text] [Related]
13. A case analysis of NEPA implementation: NIH and DNA recombinant research.
Chalker SM; Catz RS
Duke Law J; 1978 Mar; 1978(1):57-112. PubMed ID: 11661621
[No Abstract] [Full Text] [Related]
14. Recombinant DNA: guidelines debated at public hearing.
Wade N
Science; 1976 Feb; 191(4229):834-6. PubMed ID: 11643300
[No Abstract] [Full Text] [Related]
15. The DNA maelstrom.
McCann NL
Sojourners; 1977 May; 6(5):23-6. PubMed ID: 11662888
[No Abstract] [Full Text] [Related]
16. Biotech's stalled revolution.
Schneider K
N Y Times Mag; 1986 Nov; ():42-44, 47-48+. PubMed ID: 11649783
[No Abstract] [Full Text] [Related]
17. Genetics and the common man.
Norman C
Technol Rev; 1976 Feb; 78(4):8-9. PubMed ID: 11662522
[No Abstract] [Full Text] [Related]
18. The impact of biotechnology on corporate law and regulation.
Green HP
Technol Soc; 1983; 5(2):87-94. PubMed ID: 11650687
[No Abstract] [Full Text] [Related]
19. Should science be stopped? The case of recombinant DNA research.
Gershon ES
Public Interest; 1983; No. 71():3-16. PubMed ID: 11650689
[No Abstract] [Full Text] [Related]
20. Molecular biology or molecular politics? The production of scientific consensus on the hazards of recombinant DNA technology.
Wright S
Soc Stud Sci; 1986 Nov; 16(4):593-620. PubMed ID: 11650809
[No Abstract] [Full Text] [Related]
[Next] [New Search]
